1985Journal of Nuclear MedicineRequires access

Effect of therapeutic dose of heparin on in vivo labeling of red blood cells with Technetium-99m for blood-pool imaging: Importance of stannous ion concentration

S.A. Rao, J Knobel, B. David Collier

Open publisher page 0 citations

Abstract

While convenience and economy favor the use of in vivo methods for labeling red blood cells (RBC's) with technetium-99m pertechnetate, previous reports suggested that patient medication and therapy in some cases might interfere with the RBC labeling and thus resulting in inferior quality images. Using a canine model, the role of stannous ion in labeling RBC's both in the presence and absence of a therapeutic dose of heparin was investigated. The systematic investigations described in this paper suggested that 20 micrograms per kiolgrams of body weight regularly provided better than 80% labeling yields even in the presence of therapeutic dose of heparin. Superior quality blood pool images were obtained by this improved procedure.

About this research paper

What this paper is about

While convenience and economy favor the use of in vivo methods for labeling red blood cells (RBC's) with technetium-99m pertechnetate, previous reports suggested that patient medication and therapy in some cases might interfere with the RBC labeling and thus resulting in inferior quality images. Using a canine model, the role of stannous ion in labeling RBC's both in the presence and absence of a therapeutic dose of heparin was investigated. The systematic investigations described in this paper suggested that 20 micrograms per kiolgrams of body weight regularly provided better than 80% labeling yields even in the presence of therapeutic dose of heparin. Superior quality blood pool images were obtained by this improved procedure.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

While convenience and economy favor the use of in vivo methods for labeling red blood cells (RBC's) with technetium-99m pertechnetate, previous reports suggested that patient medication and therapy in some cases might interfere with the RBC labeling and thus resulting in inferior quality images. Using a canine model, the role of stannous ion in labeling RBC's both in the presence and absence of a therapeutic dose of heparin was investigated. The systematic investigations described in this paper suggested that 20 micrograms per kiolgrams of body weight regularly provided better than 80% labeling yields even in the presence of therapeutic dose of heparin. Superior quality blood pool images were obtained by this improved procedure.

Key concepts: Pertechnetate, Heparin, In vivo, Technetium-99m, Technetium-99, Technetium, Isotopes of technetium, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of therapeutic dose of heparin on in vivo labeling of red blood cells with Technetium-99m for blood-pool imaging: Importance of stannous ion concentration — Research Paper | ScholarLens